LUNG

1.42

3.40% -0.05

Pre-mercato: 1.43 0.01 +0.70%

Pulmonx Corp (LUNG)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.47

Aprire:

$1.47

Volume 24 ore:

344.16K

Relative Volume:

0.73

Capitalizzazione di mercato:

$59.98M

Reddito:

$90.50M

Utile/perdita netta:

$-54.00M

Rapporto P/E:

-1.068

EPS:

-1.3296

Flusso di cassa netto:

$-32.90M

1 W Prestazione:

-1.39%

1M Prestazione:

+4.41%

6M Prestazione:

-14.97%

1 anno Prestazione:

-68.58%

Intervallo 1D:

$1.40

$1.515

Intervallo di 1 settimana:

$1.40

$1.60

Portata 52W:

$1.13

$5.459

Pulmonx Corp Stock (LUNG) Company Profile

Nome

Pulmonx Corp

Settore

Healthcare (1114)

Industria

Medical Devices (142)

Telefono

650-364-0400

Indirizzo

700 CHESAPEAKE DRIVE, REDWOOD CITY

Dipendente

296

Cinguettio

Prossima data di guadagno

2026-04-29

Ultimi documenti SEC

LUNG's Discussions on Twitter

Compare LUNG vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LUNG Pulmonx Corp	1.42	62.09M	90.50M	-54.00M	-32.90M	-1.3296
ABT Abbott Laboratories	96.00	168.22B	45.13B	6.28B	7.40B	3.5895
SYK Stryker Corp	338.34	131.49B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	85.00	110.66B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	60.99	95.46B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	81.44	46.69B	6.07B	1.06B	1.34B	1.8063

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-31	Downgrade	Piper Sandler	Overweight → Neutral
2025-03-10	Iniziato	D. Boral Capital	Buy
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-06-04	Iniziato	Lake Street	Buy
2024-02-23	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-09-05	Iniziato	Craig Hallum	Buy
2023-02-27	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-01-03	Downgrade	BofA Securities	Neutral → Underperform
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-07-11	Downgrade	Citigroup	Buy → Neutral
2022-03-02	Ripresa	BofA Securities	Neutral
2021-12-08	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-04-01	Iniziato	Citigroup	Buy
2021-03-25	Iniziato	Piper Sandler	Neutral
2021-03-10	Aggiornamento	BofA Securities	Neutral → Buy
2021-01-04	Downgrade	BofA Securities	Buy → Neutral
2020-10-26	Iniziato	BofA Securities	Buy
2020-10-26	Iniziato	Canaccord Genuity	Buy
2020-10-26	Iniziato	Morgan Stanley	Equal-Weight
2020-10-26	Iniziato	Stifel	Buy
2020-10-26	Iniziato	Wells Fargo	Equal Weight

Mostra tutto

Pulmonx Corp Borsa (LUNG) Ultime notizie

Apr 19, 2026

How The Pulmonx (LUNG) Investment Narrative Is Resetting Around A Lower Target And Execution Risk - Yahoo Finance

Apr 19, 2026

Apr 15, 2026

Pulmonx sets April 29 earnings release, 4:30 p.m. ET webcast - Stock Titan

Apr 15, 2026

Apr 14, 2026

LUNG Stock Price, Quote & Chart | PULMONX CORP (NASDAQ:LUNG) - ChartMill

Apr 14, 2026

Apr 13, 2026

Pulmonx Corp stock (US74586W1018): Is its airway treatment edge strong enough to unlock new upside? - AD HOC NEWS

Apr 13, 2026

Apr 05, 2026

Pulmonx Insiders Forfeit On 14% Gains After Selling Stock - Sahm

Apr 05, 2026

Apr 04, 2026

How The Pulmonx (LUNG) Investment Story Is Shifting After Q4 And New Guidance - Yahoo Finance

Apr 04, 2026

Apr 03, 2026

Pulmonx (LUNG) Projects 2026 Financial Outlook with Revenue and Margin Targets - GuruFocus

Apr 03, 2026

Apr 02, 2026

Earnings call transcript: Pulmonx Q4 2025 EPS beats, revenue misses, stock dips - Investing.com

Apr 02, 2026

Mar 30, 2026

Rate Hike: Is Pulmonx Corporation stock trending bullishWeekly Profit Summary & Safe Capital Growth Plans - baoquankhu1.vn

Mar 30, 2026

Mar 27, 2026

Vanguard discloses zero Pulmonx holdings after internal realignment (NASDAQ: LUNG) - Stock Titan

Mar 27, 2026

Mar 22, 2026

If You Invested $1,000 in Pulmonx Corp (LUNG) - Stock Titan

Mar 22, 2026

Mar 21, 2026

How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions - Yahoo Finance

Mar 21, 2026

Mar 15, 2026

LUNG SEC FilingsPulmonx Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 15, 2026

Pulmonx Corp Stock (ISIN: US74586W1018) Trades at Multi-Year Lows Amid Growth Potential in Lung Ther - AD HOC NEWS

Mar 15, 2026

Mar 14, 2026

Growth Value: Should I set a stop loss on Pulmonx CorporationBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn

Mar 14, 2026

Mar 11, 2026

Pulmonx Corporation 2025 Annual Report: Innovative COPD Solutions, Zephyr Valve Clinical Data, and Global Market Strategy - Minichart

Mar 11, 2026

LUNG Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 11, 2026

Mar 10, 2026

Pulmonx (NASDAQ: LUNG) expands emphysema device business but remains unprofitable - Stock Titan

Mar 10, 2026

Pulmonx 2025 10-K: Revenue $90.5M, EPS (Loss) $(1.33) - TradingView

Mar 10, 2026

Pulmonx Corporation (LUNG) Releases Q4 2025 Earnings: Revenue Down, Diluted Loss Per Share Widens - Quiver Quantitative

Mar 10, 2026

Mar 09, 2026

Soleus group holds 2.67M Pulmonx shares (LUNG) — 6.5% stake disclosed - Stock Titan

Mar 09, 2026

Mar 06, 2026

Pulmonx Corporation (NASDAQ:LUNG) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 06, 2026

Mar 05, 2026

Pulmonx Secures $60 Million Senior Secured Term Loan From Perceptive; $40 Million Drawn - TradingView

Mar 05, 2026